Literature DB >> 28362677

Medial approach open reduction with ligamentum teres partial excision and plication for the management of congenital hip dislocation.

Ahmed O Youssef1.   

Abstract

Because of the known tendency for early redislocation following open reduction, we developed surgical methods for shortening the ligamentum teres to improve immediate postoperative stability when performing medial approach open reduction (MAOR) for the management of developmental dysplasia of the hip. Between 2004 and 2014, 32 patients with dysplasia of the hip were managed by MAOR with partial excision and plication of ligamentum teres. The patients were followed up for an average of 6.9 years. At the final follow-up, clinical outcomes achieved were categorized as excellent and good in 39 (39/40; 97.5%) hips. At the latest follow-up, 97.5% (39 hips) were classified as good or excellent on the basis of the Severin classification (Severin grade 1 or 2). In conclusion, this series of MAOR, in which ligamentum teres partial excision and plication was utilized, we found stable reduction in all hips. On the basis of these positive results, we recommend this method for children treated with MAOR. LEVEL OF EVIDENCE: Level IV: case series.

Entities:  

Mesh:

Year:  2018        PMID: 28362677     DOI: 10.1097/BPB.0000000000000455

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  2 in total

1.  A Comparative Study of Clinical and Radiological Outcomes of Open Reduction Using the Anterior and Medial Approaches for the Management of Developmental Dysplasia of the Hip.

Authors:  Omer Naci Ergin; Mehmet Demirel; Emre Meric; Volkan Sensoy; Fuat Bilgili
Journal:  Indian J Orthop       Date:  2020-06-20       Impact factor: 1.251

2.  THE ROUND LIGAMENT IN DEVELOPMENTAL HIP DYSPLASIA: ARE ITS MECHANICAL AND HISTOLOGICAL PROPERTIES PRESERVED?

Authors:  Alexandre Zuccon; Hamilton DA Rosa Pereira; Sérgio Alexandre Alcântara Dos Santos; Sérgio Luís Felisbino; Luís Antônio Justulin Junior; Daniele Cristina Cataneo
Journal:  Acta Ortop Bras       Date:  2022-01-28       Impact factor: 0.513

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.